Patient Reporting and Action for a Safe Environment (PRASE) intervention: a multi-centred evaluation

Conditions

Topic: Generic Health Relevance and Cross Cutting Themes

Jane O’Hara, Caroline Reynolds, Sally Moore, Gerry Armitage, Laura Sheard et al. (9 authors)

BMJ Quality & Safety2018-03-15132 citations

10.1136/bmjqs-2017-006974

Can patient involvement improve patient safety? A cluster randomised control trial of the Patient Reporting and Action for a Safe Environment (PRASE) intervention

Rebecca Lawton, Jane O’Hara, Laura Sheard, Gerry Armitage, Kim Cocks et al. (12 authors)

BMJ Quality & Safety2017-02-03128 citations

10.1136/bmjqs-2016-005570

Improving patient safety through the involvement of patients: development and evaluation of novel interventions to engage patients in preventing patient safety incidents and protecting them against unintended harm

John Wright, Rebecca Lawton, Jane O’Hara, Gerry Armitage, Laura Sheard et al. (17 authors)

Programme Grants for Applied Research2016-10-0147 citations

10.3310/pgfar04150

ISQUA16-2578CAN PATIENT INVOLVEMENT IMPROVE PATIENT SAFETY? A CLUSTER RANDOMIZED CONTROL TRIAL OF THE PATIENT REPORTING AND ACTION FOR A SAFE ENVIRONMENT (PRASE) INTERVENTION: Table 1

Rebecca Lawton, Laura Sheard, Jane O’Hara

International Journal for Quality in Health Care2016-10-013 citations

10.1093/intqhc/mzw104.29

Can staff and patient perspectives on hospital safety predict harm-free care? An analysis of staff and patient survey data and routinely collected outcomes

Rebecca Lawton, Jane O’Hara, Laura Sheard, Caroline Reynolds, Kim Cocks et al. (7 authors)

BMJ Quality & Safety2015-04-1080 citations

10.1136/bmjqs-2014-003691

Evaluating the PRASE patient safety intervention - a multi-centre, cluster trial with a qualitative process evaluation: study protocol for a randomised controlled trial.

Sheard L, O'Hara J, Armitage G, Wright J, Cocks K, McEachan R, Watt I, Lawton R, Yorkshire Quality & Safety Research Group.

2014-10-2922 citations

10.1186/1745-6215-15-420

Interventions

The three key stages of the process are: 1. Measurement Over a 2-3 week period, 25 patients will be asked to participate in the measurement phase on each ward. Each patient (deemed to have capacity

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Male or female 2. Aged 16 or over, upper age limit 99 years 3. Able to give informed consent 4. Minimum period of two hours on the ward before questionnaire administered 5. Parents or carers of child patients in paediatric wards

Exclusion criteria

Exclusion criteria: 1. Does not have capacity to consent 2. Children under the age of 16 3. Has capacity but is too ill or distressed to take part e.g. breathlessness, pain, bleeding, immediately post-op etc 4. Has taken part in the study within the previous month

Design outcomes

Primary

Measure	Time frame
1. Patient Safety Thermometer data; This is routinely collected ward level data which includes information on: 1.1. Pressure ulcers 1.2. Venous thromboembolism (VTE) 1.3. Catheter associated Urinary Tract Infections 1.4. Falls Timepoints: 6 month and 12 months post baseline 2. Patient Measure of Organisational Safety (PMOS) questionnaire domain scores Measured at baseline, 6 months, 12 months	—

Secondary

Measure	Time frame
1. Three CQUIN questions (from patients, at the end of the questionnaire) measured at baseline, six months, twelve months 2. Family & Friends question, which is: ?How likely are you to recommend this ward to friends and family if they needed similar care or treatment?? (from patients, at the beginning of the questionnaire) 3. Staff patient safety culture, including: 3.1. Questions from national staff survey 3.2. Staff satisfaction/morale Measured at baseline, 6 months, 12 months The trialists will also seek to access some routinely collected ward-level data from participating wards: 1. Patient safety incidents for the study period (as a secondary outcome) 2. Staff absence/sickness rates (as a covariate) 3. Patient acuity/dependency scores (as a covariate) 4. Nurse/patient ratios (as a covariate) Measured at baseline and 12 months	—

Measure

Time frame

1. Three CQUIN questions (from patients, at the end of the questionnaire) measured at baseline, six months, twelve months 2. Family & Friends question, which is: ?How likely are you to recommend this ward to friends and family if they needed similar care or treatment?? (from patients, at the beginning of the questionnaire) 3. Staff patient safety culture, including: 3.1. Questions from national staff survey 3.2. Staff satisfaction/morale Measured at baseline, 6 months, 12 months The trialists will also seek to access some routinely collected ward-level data from participating wards: 1. Patient safety incidents for the study period (as a secondary outcome) 2. Staff absence/sickness rates (as a covariate) 3. Patient acuity/dependency scores (as a covariate) 4. Nurse/patient ratios (as a covariate) Measured at baseline and 12 months

—

Countries

United Kingdom

Outcome results

None listed